Altogether, a single-cell level cytotoxicity assay based on live cell imaging revealed that the powerful CAR1-NK cells targeting CLDN6 constructed by self-active elements significantly enhanced the specifical killing efficacy against CLDN6-positive cancer cells. The gene discussed is CLDN6; the disease is cancer.